Ignite Creation Date:
2024-05-05 @ 9:07 PM
Last Modification Date:
2024-10-26 @ 9:59 AM
Study NCT ID:
NCT00810485
Status:
COMPLETED
Last Update Posted:
2012-07-16
First Post:
2008-12-17
Brief Title:
ADX10059 as an add-on Therapy to Proton Pump Inhibitors PPIs in Patients With Gastroesophageal Reflux GERD
Sponsor:
Addex Pharma SA
Organization:
Addex Pharma SA
Study Overview
Official Title:
A Phase 2B Randomised Double-blind Placebo-controlled Parallel Group Dose-ranging Multi-centre Study to Investigate the Efficacy Safety and Tolerability of the mGluR5 Negative Allosteric Modulator ADX10059 in Patients With Gastroesophageal Reflux Disease GERD Who Are Partial Responders to Proton Pump Inhibitor PPI Treatment
Status:
COMPLETED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effect of ADX10059 in patients with gastroesophageal reflux disease who are partial responders to proton pump inhibitors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2008-005105-18 | None | None | None |